Miura, Masatomo <br/><br/>
Influence of rabeprazole and lansoprazole on the pharmacokinetics of tacrolimus in relation to CYP2C19, CYP3A5 and MDR1 polymorphisms in renal transplant recipients.  [electronic resource] 

 -  Biopharmaceutics & drug disposition  May 2007 
 - 167-75 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0142-2782 
<br/><br/><label>Standard No.: </label>10.1002/bdd.544  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>2-Pyridinylmethylsulfinylbenzimidazoles--pharmacology<br/>Adult<br/>Area Under Curve<br/>Aryl Hydrocarbon Hydroxylases--drug effects<br/>Cytochrome P-450 CYP2C19<br/>Cytochrome P-450 CYP3A<br/>Cytochrome P-450 Enzyme System--drug effects<br/>Drug Interactions<br/>Enzyme Inhibitors--pharmacology<br/>Female<br/>Genes, MDR--drug effects<br/>Humans<br/>Immunosuppressive Agents--blood<br/>Kidney Transplantation<br/>Lansoprazole<br/>Male<br/>Middle Aged<br/>Mixed Function Oxygenases--drug effects<br/>Polymorphism, Genetic<br/>Rabeprazole<br/>Tacrolimus--blood